180 results found in news
news
CareAcross content
CareAcross
Posted about 5 years ago
Drugs used in prostate gland removal linked to cancer outcome, study finds
Opioids (painkillers commonly given during and after surgery) may suppress the immune system's ability to fight cancer cells, leading to a suggestion that supplementing general anesthesia with a spinal or epidural painkiller before a radical prostatectomy reduces a patient's need for opioids after surgery, and this finding was associated with a lower risk of cancer recurrence.
Read full article
CareAcross content
CareAcross
Posted about 5 years ago
“One-stop” radiotherapy could offer an alternative to lengthy and inconvenient post-surgery procedures for breast cancer
Two new studies, published in The Lancet and The Lancet Oncology, show that targeted radiotherapy delivered during surgery could offer a viable alternative to current procedures – which require women to attend daily radiotherapy sessions for weeks after surgery – for some women undergoing surgery for early breast cancer.
Read full article
CareAcross content
CareAcross
Posted about 5 years ago
ASCO highlights five cancer treatments routinely performed despite lack of evidence
The American Society of Clinical Oncology (ASCO) announced its second “Top Five” list of opportunities to improve the quality and value of cancer care. Published in the Journal of Clinical Oncology (JCO), ASCO’s second Top Five list was released as part of the Choosing Wisely® campaign, sponsored by the ABIM Foundation, to encourage conversations between physicians and patients aimed at curbing the use of certain tests and procedures that are not supported by clinical research. One of the first nine medical societies to join the Choosing Wisely campaign, ASCO issued its first Top Five list in April 2012.
Read full article
CareAcross content
CareAcross
Posted about 5 years ago
Patient-reported outcomes provide valuable insight regarding quality of life for patients with non-small cell lung cancer
An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
Read full article